XOMA Corp Financials
| XOMAP Preferred Stock | USD 25.75 0.02 0.08% |
XOMA |
Understanding current and past XOMA Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of XOMA Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in XOMA Corp's assets may result in an increase in income on the income statement.
XOMA Corp Preferred Stock Summary
XOMA Corp competes with Harrow Health, SiriusPoint, New York, and Sachem Capital. XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Xoma Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Preferred Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US98419J3059 |
| CUSIP | 98419J305 |
| Location | California; U.S.A |
| Business Address | 2200 Powell Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.xoma.com |
| Phone | 510 204 7200 |
| Currency | USD - US Dollar |
XOMA Corp Key Financial Ratios
XOMA Corp's financial ratios allow both analysts and investors to convert raw data from XOMA Corp's financial statements into concise, actionable information that can be used to evaluate the performance of XOMA Corp over time and compare it to other companies across industries.XOMA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XOMA Corp's current stock value. Our valuation model uses many indicators to compare XOMA Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XOMA Corp competition to find correlations between indicators driving XOMA Corp's intrinsic value. More Info.XOMA Corp is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for XOMA Corp is roughly 1.79 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the XOMA Corp's earnings, one of the primary drivers of an investment's value.XOMA Corp Systematic Risk
XOMA Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. XOMA Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on XOMA Corp correlated with the market. If Beta is less than 0 XOMA Corp generally moves in the opposite direction as compared to the market. If XOMA Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one XOMA Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of XOMA Corp is generally in the same direction as the market. If Beta > 1 XOMA Corp moves generally in the same direction as, but more than the movement of the benchmark.
XOMA Corp November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of XOMA Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of XOMA Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of XOMA Corp based on widely used predictive technical indicators. In general, we focus on analyzing XOMA Preferred Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build XOMA Corp's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.7726 | |||
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 4.61 | |||
| Value At Risk | (1.16) | |||
| Potential Upside | 1.28 |
Additional Tools for XOMA Preferred Stock Analysis
When running XOMA Corp's price analysis, check to measure XOMA Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XOMA Corp is operating at the current time. Most of XOMA Corp's value examination focuses on studying past and present price action to predict the probability of XOMA Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XOMA Corp's price. Additionally, you may evaluate how the addition of XOMA Corp to your portfolios can decrease your overall portfolio volatility.